These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stimulatory effect of endogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpression on type IV collagen and laminin gene expression in rat mammary carcinoma cells. Yoshiji H; Buck TB; Harris SR; Ritter LM; Lindsay CK; Thorgeirsson UP Biochem Biophys Res Commun; 1998 Jun; 247(3):605-9. PubMed ID: 9647740 [TBL] [Abstract][Full Text] [Related]
5. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]
6. Human breast carcinoma desmoplasia is PDGF initiated. Shao ZM; Nguyen M; Barsky SH Oncogene; 2000 Sep; 19(38):4337-45. PubMed ID: 10980609 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
8. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related]
9. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
10. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246 [TBL] [Abstract][Full Text] [Related]
11. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease. Szabova L; Chrysovergis K; Yamada SS; Holmbeck K Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307 [TBL] [Abstract][Full Text] [Related]
12. Structural alterations within N-nitrosomethylurea-induced mammary tumors after in vivo treatment with cis-hydroxyproline. Strum JM; Lewko WM; Kidwell WR Lab Invest; 1981 Oct; 45(4):347-54. PubMed ID: 7300247 [TBL] [Abstract][Full Text] [Related]
13. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer. Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163 [TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4. Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414 [TBL] [Abstract][Full Text] [Related]
16. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379 [TBL] [Abstract][Full Text] [Related]
17. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Davies B; Brown PD; East N; Crimmin MJ; Balkwill FR Cancer Res; 1993 May; 53(9):2087-91. PubMed ID: 8347186 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307 [TBL] [Abstract][Full Text] [Related]